Document is current
Any future updates will be listed below
-
Authors
Rozenbaum, Mark H. https://orcid.org/0000-0001-6209-4370
Tort, Maria J. https://orcid.org/0000-0002-6088-451X
Chapman, Ruth
Perez, Katherine K. https://orcid.org/0000-0002-7535-997X
Dillon-Murphy, Desmond
Althouse, Benjamin M. https://orcid.org/0000-0002-5464-654X
Farkouh, Raymond
-
Funding
Funding for this research was provided by:
Pfizer
- License Information
-
More Information
Article History
Received: 30 July 2025
Accepted: 25 September 2025
First Online: 27 October 2025
Declarations
:
: Mark H. Rozenbaum, Maria J. Tort, Katherine K. Perez, Benjamin M Althouse, Raymond Farkouh, and Mark Rozenbaum are employed by Pfizer Inc. and hold Pfizer stock. Ruth Chapman and Desmond Dillon-Murphy are employees of Evidera Inc., which received funding from Pfizer in connection with this study and the development of this manuscript.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
